May 19, 2015 7:28am
BLUE pursues conditional and accelerated registration strategies in E.U. and U.S., Respectively
Plans to pursue conditional approval in E.U. based on data from ongoing Northstar and HGB-205 studies through Adaptive Pathways Pilot Program
NIH RAC will review HGB-208 Pediatric Study Protocol on 6/9/15
Members only. Please login.